Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN64375246) titled 'Adding casein phosphopeptides (CPP) to infant formula to support growth and bone development in 6-8-month-old infants' on Oct. 23.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Prevention
Primary Sponsor: Shanghai Jiao Tong University
Condition:
Suboptimal mineral absorption and bone mineralisation in formula-fed infants aged 6-8 months (healthy infants
prevention-oriented nutritional intervention).
Musculoskeletal Diseases
Intervention:
Experimental arm: Base infant formula supplemented with cas...